Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Oct 15, 2025; 16(10): 112631
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.112631
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.112631
Early predictors of carotid atherosclerosis in patients with type 2 diabetes mellitus
Alexander E Berezin, Department of Internal Medicine-II, Paracelsus Medical University Salzburg, Salzburg 5020, Austria
Author contributions: Berezin AE is solely author of the manuscript who contributed to the study design, drafted the manuscript, made the figure, revised the final version of the manuscript, has reviewed and approved the manuscript and consented to its publication.
Conflict-of-interest statement: There are no conflicts of interests.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Alexander E Berezin, MD, PhD, FACC, FESC, Professor, Department of Internal Medicine-II, Paracelsus Medical University Salzburg, 21 Strubergasse, Salzburg 5020, Austria. aeberezin@gmail.com
Received: August 4, 2025
Revised: August 18, 2025
Accepted: September 3, 2025
Published online: October 15, 2025
Processing time: 75 Days and 14 Hours
Revised: August 18, 2025
Accepted: September 3, 2025
Published online: October 15, 2025
Processing time: 75 Days and 14 Hours
Core Tip
Core Tip: The integration of routinely used biomarkers of kidney dysfunction (urinary albumin-to-creatinine ratio) and metabolic abnormality (serum uric acid, high-density lipoprotein cholesterol) to predictive model may be practically useful to pre-screen the patients with type 2 diabetes mellitus at higher risk of carotid atherosclerotic plaque.